Noteworthy

Oct 01, 2011
Pharmaceutical Executive
Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.
Oct 01, 2011
Pharmaceutical Executive
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
Oct 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Success in the emerging markets depends significantly on navigating the myths and mental traps.
Oct 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pharm Exec sits down with Steve Collis, CEO of AmerisourceBergen to discuss his agenda for retooling the drug distribution giant.
Sep 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Especially when payers come to the table holding the best cards — leaving industry second-guessing its strategy.
Sep 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Richard Barker, former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.
Sep 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Can cooperative ties between Big Pharma, NGOs, government, and international organizations pay the freight in making the fight against neglected diseases a permanent fix in global health?
Sep 01, 2011
Pharmaceutical Executive
The time is right for industry to overcome its social media phobia once and for all.
Sep 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Diagnostics can bost the efficacy of drug treatments, but delivering the promise depends on a predictible pathway to reimbursement.
Sep 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Bill Trombetta surveys the landscape of pharma financials over the past year, and shows which companies rode the wave to the top of the industry in delivering value to shareholders.
native1_300x100
lorem ipsum